YS

YS Biopharma Co., Ltd. · NASDAQ

Performance

-4.28%

1W

+34.59%

1M

+64.4%

3M

+26.01%

6M

+68.3%

YTD

-43.05%

1Y

Profile

YS Biopharma Co., Ltd., a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. The company develops a proprietary PIKA immunomodulating technology platform and a series of product targeting PIKA rabies vaccine, PIKA recombinant COVID-19 vaccine, and PIKA YS-ON-001. It operates in China, the United States, Singapore, the United Arab Emirates, and the Philippines. The company was founded in 2002 and is based in Beijing, China.

Technical Analysis of YS 2024-04-12

Overview:

In analyzing the technical indicators for YS stock over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key indicators, we aim to offer valuable insights and predictions for informed ...

See more ...

Recent News & Updates